Unfractionated Heparin 5,000 IU/mL

Auto-translated from French

Original title: HEPARINE NON FRACTIONNEE 5 000 UI/ML

HUmani SC

Published: Jun 30, 2026

Updated: Jun 30, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Belgium, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before July 28, 2026.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: French

This tender, originating from Belgium and sourced via ted, concerns the procurement of 'HEPARINE NON FRACTIONNEE 5 000 UI/ML'. This clearly indicates a requirement for a specific pharmaceutical product: unfractionated heparin at a concentration of 5,000 IU/mL. The contracting authority is seeking a reliable supply of this essential medication. Such procurements are typically conducted by healthcare institutions, hospitals, or public health bodies. The tender will likely specify stringent quality control measures, adherence to pharmacopoeial standards (e.g., European Pharmacopoeia), and requirements for proper storage, handling, and distribution of pharmaceutical products. Bidders are expected to be licensed pharmaceutical manufacturers or authorized distributors with the capacity to supply the specified product in the required quantities and packaging. Compliance with Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) will be paramount. The evaluation criteria will focus on product quality, supplier reliability, delivery timelines, and competitive pricing, ensuring patient safety and uninterrupted availability of critical medication.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on June 30, 2026. Last refreshed today. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About HUmani SC

HUmani SC has issued 29 procurement notices on BidsFactory, including 7 currently open and 5 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: June 30, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by HUmani SC in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is July 28, 2026. You have 28 days left to prepare and submit your proposal to the contracting authority.